Document:

Exhibit
10.85

 

THEMAVEN,
INC.

 

STOCK
OPTION AWARD AGREEMENT

 

This
Stock Option Award Agreement (“Agreement”) is made and entered into by and between THEMAVEN, INC., a Delaware corporation
(the “Company”) and Douglas B. Smith (“Participant”). This Agreement is entered into separate from
any equity incentive or similar plan, however the provisions of Sections 2, 6, 7, 8, 9, 10, 11, 12 and 13 of the 2016 Stock Incentive
Plan of the Company (the “Plan”) are incorporated herein by reference. All capitalized terms not defined in this Agreement
have the meanings set forth in the Plan.

 

1.
Grant. Subject to the Plan, the Company grants to the Participant an option (“Option”) to purchase shares of
the common stock of the Company as follows:

 

	Participant:	Douglas
    B. Smith
	 	 
	Grant
    Date: 	March
    11, 2019
	 	 
	Vesting
    Start Date:	March
    1, 2019
	 	 
	Shares:	Common
    Stock 
	 	 
	Shares
    Subject to Option:	1,000,000
	 	 
	Exercise
    Price:	$0.57
    per share
	 	 
	Type
    of Option:	Nonqualified
    Stock Option
	 	 
	Option
    Expiration Date:	March
    11, 2029
	 	 
	 	(subject
    to early termination in accordance with the terms of the Plan incorporated herein by reference)
	 	 
	Vesting
    Period:	Monthly
    vesting over 36 months, with 1/3 vesting after 12 months of Continuous Service (which shall include both service provided under the
    Service Agreement dated as of March 1, 2019 between Hampshire Road Advisors, LLC, of which Participant is the principal, and Maven
    Coalition, Inc., a Nevada corporation and wholly-owned subsidiary of the Company (“Continuous Service”)) following
    the Vesting Start Date and 1/36th vesting at the end of each month of Continuous Service thereafter, each as described in the stock
    option documents

     

    In
    addition, the Option vesting will accelerate, and any outstanding portion of the Option will be fully vested, upon the occurrence
    of (i) a Corporate Transaction during Participant’s Continuous Service, and (ii) in connection with the Corporate Transaction,
    or within six (6) months following the Corporate Transaction, Participant’s Continuous Service ends.

     

    “Corporate
    Transaction” means the occurrence, in a single transaction or in a series of related transactions, of any one or more of
    the following events:

     

 

    	 	 	 

     

    

 

	 	(i)
    the consummation of a sale or other disposition of all or substantially all, as determined by the Board in its sole discretion, of
    the consolidated assets of the Company and its Subsidiaries;
	 	 
	 	(ii)
    the consummation of a sale or other disposition of more than fifty percent (50%) of the outstanding securities of the Company;

     

	 	 
	 	(iii)
    the consummation of a merger, consolidation or similar transaction following which the Company is not the surviving corporation;
    or
	 	 
	 	(iv)
    the consummation of a merger, consolidation or similar transaction following which the Company is the surviving corporation but the
    shares of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged
    by virtue of the merger, consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise.

 

THE
GRANT OF THE OPTION IS MADE IN CONSIDERATION OF THE SERVICES TO BE RENDERED BY THE PARTICIPANT TO THE COMPANY AND IS SUBJECT TO THE TERMS
AND CONDITIONS OF THE PLAN INCORPORATED HEREIN BY REFERENCE. THE OPTION MAY BE EXERCISED ONLY FOR WHOLE SHARES.

 

2.
Option Provisions.

 

2.1
Termination. Subject to the provisions of the Vesting Period set forth above, upon the termination of the employment of the Participant
with the Company and all Subsidiaries for any reason other than death, Disability, or Retirement, or if Participant is in the employ
of a Subsidiary and the Subsidiary ceases to be a Subsidiary of the Company (unless the Participant continues in the employ of the Company
or another Subsidiary), then (a) all vesting of the Option shall immediately cease and (b) any and all Options then held by the Participant
will, to the extent vested as of such termination of employment, remain exercisable in full for a period of one (1) month after such
termination of employment (but in no event after the expiration date of any such Option), unless the termination is for Cause. If termination
of employment is for Cause (as defined in the Employment Agreement), all Options shall immediately terminate as further provided in the
Plan. If the termination of employment is due to Disability or Retirement, then the Option shall be exercisable as provided in the Plan.

 

2.2
Exercise. To exercise the Option, the Participant (or person then entitled to exercise the Option under the Plan) must deliver
to the Company an executed stock option exercise agreement in such form as is approved by the Committee from time to time (“Exercise
Agreement”), which shall set forth, inter alia: (a) the Participant’s election to exercise the Option; (b) the number
of shares of Common Stock being purchased; (c) any restrictions imposed on the shares of Common Stock being purchased; and (d) such representations,
warranties, and agreements regarding the Participant’s investment intent and access to information as may be required by the Company
to comply with applicable securities laws.

 

The
shares that may be issued on exercise of this Option, at the time of the grant hereof, are not authorized and available for issuance,
therefore this Option is currently considered an unfunded option. The Participant agrees that no part of this Option may be exercised
until the later of the increase in the authorized shares of common stock in sufficient number of shares to permit the exercise from time
to time of this Option or the later respective vesting and exercise date as set forth herein.

 

    	2

     

    

 

2.3
Payment of Exercise Price. The Exercise Price of the Option shall be payable in full in cash, or its equivalent at the time of
exercise in the manner then designated by the Committee, unless otherwise agreed by the Committee.

 

2.4
Vesting. All Options not vested will be terminated and forfeited upon the Participant’s termination of employment. Any and
all Options that have not vested as provided in Section 1 of this Agreement shall terminate immediately upon the termination,
for any reason whatsoever, of the employment of the Participant with the Company and all Subsidiaries, or if Participant is in the employ
of a Subsidiary and the Subsidiary ceases to be a Subsidiary of the Company (unless the Participant continues in the employ of the Company
or another Subsidiary).

 

3.
Taxation.

 

3.1
Tax Liability and Withholding. Notwithstanding any action the Company takes with respect to any or all income tax, social insurance,
payroll tax, or other tax-related withholding (“Tax-Related Items”), the ultimate liability for all Tax-Related Items
is and remains the Participant’s sole responsibility. The Company makes no representation or undertakings regarding the treatment
of any Tax-Related Items in connection with the grant, vesting, or exercise of the Option or the subsequent sale of any shares of Common
Stock acquired on exercise and does not commit to structure the Option to reduce or eliminate the Participant’s liability for Tax-Related
Items.

 

3.2
Disqualifying Disposition. If the Option is an ISO and the Participant disposes of the shares of Common Stock prior to the expiration
of either two (2) years from the Grant Date or one (1) year from the date the shares are transferred to the Participant pursuant to the
exercise of the Option, the Participant shall notify the Company in writing within thirty (30) days after such disposition of the date
and terms of such disposition. The Participant also agrees to provide the Company with any information concerning any such dispositions
as the Company requires for tax purposes.

 

4.
Compliance with Law. The exercise of the Option and the issuance and transfer of the shares of Common Stock shall be subject to
compliance by the Company and the Participant with any and all applicable requirements of federal and state securities laws and with
all applicable requirements of any stock exchange on which the Company’s shares of Common Stock may be listed. No shares of Common
Stock shall be issued pursuant to this Option unless and until any then-applicable requirements of state or federal laws and regulatory
agencies have been fully complied with to the satisfaction of the Company and its counsel. The Participant understands that the Company
is under no obligation to register the shares with the Securities and Exchange Commission, any state securities commission, or any stock
exchange to effect such compliance.

 

5.
General Terms.

 

5.1
Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original but all of which together
will constitute one and the same instrument. Counterpart signature pages to this Agreement transmitted by electronic means intended to
preserve the original graphic and pictorial appearance of a document will have the same effect as physical delivery of the paper document
bearing an original signature.

 

5.2
Discretionary Nature of Plan. The provisions of the Plan incorporated herein are discretionary and may be amended, cancelled,
or terminated by the Company at any time, in its discretion. The grant of the Option in this Agreement does not create any contractual
right or other right to receive any Options or other Awards in the future. Future Awards, if any, will be at the sole discretion of the
Company. Any amendment, modification, or termination of the Plan shall not constitute a change or impairment of the terms and conditions
of the Participant’s employment with the Company.

 

    	3

     

    

 

5.3
Governing Law. This Agreement will be construed and interpreted in accordance with the laws of the State of Delaware without regard
to conflict of law principles.

 

5.4
Interpretation. Any dispute regarding the interpretation of this Agreement shall be submitted by the Participant or the Company
to the Committee for review. The resolution of such dispute by the Committee shall be final and binding on the Participant and the Company.

 

5.5
No Right to Continued Employment; No Rights as Shareholder. Neither the Plan nor this Agreement shall confer upon the Participant
any right to be retained in any position with the Company. Nothing in the Plan or this Agreement shall be construed to limit the discretion
of the Company to terminate the employment of Participant at any time, with or without Cause. The Participant shall not have any rights
as a shareholder with respect to any shares of Common Stock subject to the Option unless and until certificates representing the shares
have been issued by the Company to the holder of such shares, or the shares have otherwise been recorded on the books of the Company
or of a duly authorized transfer agent as owned by such holder.

 

5.6
Options Subject to Plan. In the event of a conflict between any term or provision contained herein and a term or provision of
the Plan, the applicable terms and provisions of the Plan will govern and prevail.

 

5.7
Severability. The invalidity or unenforceability of any provision of the Plan or this Agreement shall not affect the validity
or enforceability of any other provision of the Plan or this Agreement, and each provision of the Plan and this Agreement shall be severable
and enforceable to the extent permitted by law.

 

5.8
Successors and Assigns. The Company may assign any of its rights under this Agreement. This Agreement will be binding upon and
inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Agreement
will be binding upon the Participant and the Participant’s beneficiaries, executors, administrators and the person(s) to whom this
Agreement may be transferred by will or the laws of descent or distribution.

 

[SIGNATURE
PAGE TO STOCK OPTION AWARD AGREEMENT

 

TO
FOLLOW]

 

    	4

     

    

 

[SIGNATURE
PAGE TO STOCK OPTION AWARD AGREEMENT]

 

	THEMAVEN,
    INC. 
	 
	 	/s/
    Paul Edmondson	 
	By:	Paul
    Edmondson	 
	Title:    	Chief
    Operating Officer	 
	Date:	 March 11, 2019	 

 

	 	PARTICIPANT 
	 	 	 
	 	 	/s/
    Douglas B. Smith
	 	Name:    	Douglas
    B. Smith
	 	 	Date: March 11, 2019

 

PARTICIPANT
ACKNOWLEDGES RECEIPT OF A COPY OF THE PLAN AND THIS AGREEMENT. PARTICIPANT HAS READ AND UNDERSTANDS THE TERMS AND PROVISIONS THEREOF,
AND ACCEPTS THE OPTION SUBJECT TO ALL OF THE TERMS AND CONDITIONS OF THE PLAN THAT ARE INCORPORATED HEREIN BY REFERENCE AND THIS AGREEMENT.
PARTICIPANT ACKNOWLEDGES THAT THERE MAY BE ADVERSE TAX CONSEQUENCES UPON EXERCISE OF THE OPTION OR DISPOSITION OF THE UNDERLYING SHARES
AND THAT THE PARTICIPANT SHOULD CONSULT A TAX ADVISOR PRIOR TO SUCH EXERCISE OR DISPOSITION.

 

Attachments:

 

Exhibit
1- Plan 

 

    	5

     

    

 

EXHIBIT
1

 

PLAN

 

See
attached.

 

    	6Exhibit 10.140

 

AMENDED
& RESTATED EXECUTIVE EMPLOYMENT AGREEMENT

 

This
Amended and Restated Executive Employment Agreement (this “Agreement”) is made and entered into as of June 14, 2020
(the “Effective Date”) between TheMaven, Inc., a Delaware corporation (the “Company”) and Avi Zimak,
an individual (the “Executive”).

 

RECITALS

 

WHEREAS,
the Company desires to continue to employ the Executive as Chief Revenue Officer and Head of Global Strategic Partnerships, and the Executive
desires to accept this offer of employment, effective as of the Effective Date.

 

WHEREAS,
the Company and the Executive entered into an Executive Employment Agreement (“Initial Agreement”), dated November
2, 2019.

 

WHEREAS,
on March 30, 2020 the Executive and the Company entered into a letter agreement providing that the Executives Annual Salary under the
Initial Agreement would be reduced to $427,500 per annum effective April 1, 2020.

 

WHEREAS,
on June 4, 2020 the Company notified the Executive that the Executive’s Annual Salary would be reduced to $363,375 per annum, effective
from the Effective Date through December 31, 2020.

 

WHEREAS,
the Company and the Executive have determined that the terms and conditions of this Agreement are reasonable and in their mutual best
interests and accordingly desire to enter into this Agreement in order to provide for the terms and conditions upon which the Executive
shall continue to be employed by the Company.

 

NOW
THEREFORE, in consideration of the foregoing and the respective covenants, agreements and representations and warranties set forth
herein, the parties to this Agreement, intending to be legally bound, agree as follows:

 

Article
1. 

TERMS
OF EMPLOYMENT

1.1.
Employment and Acceptance.

 

(a).
Employment and Acceptance. On and subject to the terms and conditions of this Agreement, the Company shall continue to employ
the Executive and the Executive hereby accepts such employment. The Initial Agreement is terminated and fully superseded by this Agreement.

 

(b).
Title: Executive shall have the title of: Chief Revenue Officer and Head of Global Strategic Partnerships.

 

(c).
Responsibilities and Duties. The Executive’s duties shall consist of such duties and responsibilities as are consistent
with the position of a Chief Revenue Officer and Head of Global Strategic Partnerships, including duties and responsibilities as are
mutually determined from time to time by the Chief Executive Officer of the Company (the “CEO”) and the Executive.

 

    	 

    	 

    

 

(d).
Reporting. The Executive shall report directly to the CEO.

 

(e).
Performance of Duties; Travel. With respect to Executive’s duties hereunder, at all times, the Executive shall be subject
to the reasonable instructions, control, and direction of the Board, and act in accordance with the Company’s Certificate of Incorporation,
bylaws and other governing policies, rules and regulations (copies of which shall be provided to Executive), except to the extent that
the Executive is aware that such documents conflict with applicable law. The Executive shall devote Executive’s business time,
attention and ability to serving the Company on an exclusive and full-time basis as aforesaid and as the CEO may reasonably require,
provided that the foregoing shall not prevent the Executive from (i) serving on the boards of non-profit organizations, upon advance
written approval from the CEO or Chief Operating Officer (“COO”), which shall not be unreasonably withheld, or (ii)
managing the Executive’s and Executive’s family’s passive personal investments, so long as such activities in the aggregate
do not materially interfere or materially conflict with the Executive’s duties hereunder. The Executive will promptly disclose
to the Company any conflicts or potential conflicts of interest, and may not perform any decision-making role in any activities in which
such a conflict arises. The Executive shall also travel as reasonably required by Executive’s duties hereunder and shall comply
with the Company’s then-current travel policies as approved by the CEO. During the term of this Agreement, Executive shall be entitled
to business class travel for all air travel related to the performance of his services hereunder on the same basis as the CEO (but in
all cases on air travel in excess of four hours in duration).

 

(f).
Location. Executive shall be based primarily in the Company’s New York City office.

 

(g).
Officer. The Executive shall, if requested, also serve as an officer of the Company or of any affiliate of the Company for no
additional compensation.

 

1.2
Compensation and Benefits.

 

(a).
Annual Salary. The Executive shall receive an annual salary of $363,375 with respect to that portion of calendar 2020 following
the Effective Date, and thereafter $450,000 (such annual base salary, as such amount may be increased in accordance with this Agreement,
the “Annual Salary”), which may not be decreased without the consent of the Executive. The Annual Salary shall be
payable in accordance with the payment schedule as used by the Company for its senior-level Executives from time to time (but with pro-rata
installments paid at least twice per calendar month), less such deductions as shall be required to be withheld by applicable law and
regulation and consistent with the Company’s practices. The Annual Salary payable to the Executive will be reviewed, and may be
increased, annually by the CEO.

 

(b).
Bonus.

 

(i).
For each calendar year during the Term starting with calendar year 2019, the Executive shall be eligible to earn an annual bonus (the
“Annual Bonus”) based on a target amount (the “Base Bonus”) of $375,000 with respect to calendar
year 2020 and $450,000 with respect to calendar years 2021 and beyond, such amount to be pro-rated for partial years. The Annual Bonus
payable for any calendar shall equal the product of the applicable Base Bonus multiplied by a factor (the “Bonus Multiple”)
determined as follows:

 

    	-2-

    	 

    

 

(A).
In the event that in any calendar year the Company achieves less than 60% of the Annual Revenue Target, the Bonus Multiple shall be 0%.

 

(B).
In the event that in any calendar year the Company achieves 60% or more, but less than 100% of the Annual Revenue Target, the Bonus Multiple
shall be is 30% + 1.75% x (% of Annual Revenue Target - 60%).

 

(C).
In the event that in any calendar year the Company achieves 100% or more, but less than 150% of the Annual Revenue Target, the Bonus
Multiple shall be 100% + 2.00% x (% of Annual Revenue Target - 100%).

 

(D).
In the event that in any calendar year the Company achieves 150% or more of the Annual Revenue Target, the Bonus Multiple shall be 200%.

 

(ii).
Bonus payments will be made quarterly (each a “Quarterly Payment”). Each Quarterly Payment will be based on the achievement
in such quarter of a portion of the Annual Revenue Target then in effect (each such amount, the “Quarterly Revenue Marker”)
as follows: (w) the Quarterly Revenue Marker for the first quarter of each calendar year shall equal 20% of the Annual Revenue Target,
(x) the Quarterly Revenue Marker for the second quarter of each calendar year shall equal 20% of the Annual Revenue Target, (y) the Quarterly
Revenue Marker for the third quarter of each calendar year shall equal 25% of the Annual Revenue Target and (z) the Quarterly Revenue
Marker for the fourth quarter of each calendar year shall equal 35% of the Annual Revenue Target. The amount of each Quarterly Payment
will be determined as follows:

 

(A).
In the event that in any calendar quarter the Company achieves less than 60% of the applicable Quarterly Revenue Marker, no Quarterly
Payment shall be payable.

 

(B).
In the event that in any calendar quarter the Company achieves 60% or more of the applicable Quarterly Revenue Marker, the Quarterly
Payment shall equal (1) 25% of the Base Bonus multiplied by (2) the lesser of (x) the portion of the Annual Revenue Target achieved in
such quarter divided by the applicable Quarterly Revenue Marker and (y) one.

 

Each
Quarterly Payment will be paid within one and a half months of the end of the applicable quarter, provided the Executive remains an employee
in good standing with the Company as of the date of payment. Notwithstanding the foregoing, in the event Executive dies, becomes Permanently
Incapacitated, is terminated without Cause or resigns for Good Reason, Executive shall be entitled to receive the Annual Bonus that would
have been earned by the Executive had the Executive been employed with the Company as of the date of payment of such Annual Bonus for
such calendar year, such amount to be pro-rated for partial years (including, for the avoidance of doubt, partial years by reason of
such termination occurring prior to December 31 of such calendar year). In the event Executive dies, becomes Permanently Incapacitated,
is terminated without Cause or resigns for Good Reason, any payment pursuant to this Section 1.2(b)(ii) is subject to the obligations
set forth in Section 1.3(c)(iii). Notwithstanding the forgoing, the parties agree that no Quarterly Payment shall be made with respect
to the first quarter of 2020.

 

    	-3-

    	 

    

 

(iii).
Within 60 days following the end of the applicable calendar year, the Company shall conduct a reconciliation (a “Reconciliation”)
of the Quarterly Payments for such calendar year against the actual Annual Bonus earned for such year and provide the Executive with
a breakdown in accordance with the notice provisions of the Agreement (“Reconciliation Notice”). It is specifically
understood that if Executive’s employment ends prior to the end of the applicable year, the calculations the Annual Bonus under
this Section 1.2(b)(iii) will be pro-rated based on the amount of time during such year for which the payment of such Annual Bonus was
earned under Section 1.2(b)(ii).

 

(iv).
In the event it is determined as a result of the Reconciliation that the sum of the Quarterly Payments was less than the actual Annual
Bonus for the applicable calendar year, the Company will pay the difference to the Executive within 30 days following the sending of
the Reconciliation Notice. In the event of an overpayment to the Executive, such overpayment shall be deducted from the subsequent Quarterly
Payment (but such deduction shall not be reflected in the Reconciliation for such subsequent period).

 

(c).
Stock Option Grant in Initial Agreement. In consideration of entering into the Initial Agreement, the Company granted to the Executive
a ten-year option (the “Option”) to purchase up to an aggregate of 2,250,000 shares of the common stock (“Common
Stock”) of the Company (the “Option Shares”) pursuant to the Company’s 2019 Equity Incentive Plan
(the “Plan”). The Option shall be subject to the terms and conditions set forth in the Plan. The Option shall vest
as follows:

 

(i).
In accordance with the terms of the Plan, the portion of the Option to acquire 1,125,000 Option Shares (the “Performance Option”)
of Common Stock will vest based on the performance targets set forth in paragraphs (A), (B) and (C) below:

 

(A).
On December 31, 2020:

 

(1)
In the event the Company achieves the Annual Revenue Target for 2020, the Performance Option with respect to 375,000 Option Shares shall
vest;

 

(2)
In the event the Company achieves 80% or more, but less than 100%, of the Annual Revenue Target for 2020, the Performance Option with
respect to a number of Option Shares shall vest equal to the percentage of the Annual Revenue Target achieved multiplied by 375,000 shares;
or

 

(3)
In the event the Company achieves less than 80% the Annual Revenue Target for 2020, the Performance Option with respect to no Option
Shares shall vest.

 

    	-4-

    	 

    

 

(B).
On December 31, 2021:

 

(1)
In the event the Company achieves the Annual Revenue Target for 2021, the Performance Option with respect to 375,000 Option Shares shall
vest;

 

(2)
In the event the Company achieves 80% or more, but less than 100%, of the Annual Revenue Target for 2021, the Performance Option with
respect to a number of Option Shares shall vest equal to the percentage of the Annual Revenue Target achieved multiplied by 375,000 shares;
or

 

(3)
In the event the Company achieves less than 80% the Annual Revenue Target for 2021, the Performance Option with respect to no Option
Shares shall vest.

 

(C).
On December 31, 2022:

 

(1)
In the event the Company achieves the Annual Revenue Target for 2022, the Performance Option with respect to 375,000 Option Shares shall
vest;

 

(2)
In the event the Company achieves 80% or more, but less than 100%, of the Annual Revenue Target for 2022, the Performance Option with
respect to a number of Option Shares shall vest equal to the percentage of the Annual Revenue Target achieved multiplied by 375,000 shares;
or

 

(3)
In the event the Company achieves less than 80% the Annual Revenue Target for 2022, the Performance Option with respect to no Option
Shares shall vest.

 

(ii).
In accordance with the terms of the Plan, the portion of the Option to acquire 1,125,000 Option Shares (the “Time Option”)
is subject, among other restrictions set forth in the Plan, to monthly vesting over 36 months commencing from the Effective Date of the
Initial Agreement, with 1/3 vesting after 12 months, and 1/36th vesting at the end of each month thereafter and concluding
36 months from the Effective Date, and to the Company’s right to cancel a portion the Time Options as described in the Plan.

 

(iii).
In connection with the Options:

 

(A).
The parties agree that the Executive’s services under the Initial Agreement and his services hereunder shall be deemed to constitute
continuous service for the purposes of the vesting of the Option.

 

(B).
The Executive acknowledges that as of the date of this Agreement, the Option Shares are not authorized and available for issuance, therefore
the Options are considered to be unfunded options. The Executive agrees that no portion of the Option may be exercised except in accordance
with the vesting conditions and exercise dates set forth in this Agreement. The Company agrees to timely increase the authorized shares
of common stock of the Company in sufficient number of shares to permit the exercise from time to time of the Option in accordance with
the vesting conditions and exercise dates set forth in this Agreement.

 

    	-5-

    	 

    

 

(C).
If the majority of C-level executives are provided additional Common Stock, options or other equity incentives by the board of directors
as part of an incentive plan or otherwise, the Executive will participate in such grants or incentive plan on the same terms and conditions
and on a pro-rata basis, compared to the average increase in shares for other adjacent C-level executives (not including the CEO). Notwithstanding
the forgoing, the Executive will not be eligible to participate in grants or incentives to the extent awarded to other personnel to address
dilution resulting from or in connection with the acquisition by the Company of TheStreet, Inc. or the entry by the Company into that
certain Licensing Agreement dated as of June 14, 2019 between the Company and ABG-SI LLC.

 

(d).
Restricted Stock Unit Award. As consideration for entering into the Initial Agreement, the Company awarded the Executive restricted
stock units (the “RSU Grant”) for 250,000 shares of Common Stock (the “RSU Shares”). The RSU Grant
shall vest on the first anniversary of the Effective Date of the Initial Agreement, so long as the Executive is continuously employed
by the Company or any affiliate thereof, and the underlying RSU Shares shall be delivered to Executive upon the earlier to occur of (i)
the 5th anniversary of the date of the Initial Agreement and (ii) the date of any change of control transaction of the Company.
The Executive acknowledges that at the time of the RSU Grant the RSU Shares are not authorized and available for issuance, therefore
the RSU Grant is considered to be unfunded. The Executive agrees that no part of RSU Grant may vest except in accordance with the vesting
conditions and exercise date set forth in this Agreement. The Company agrees to timely increase the authorized shares of common stock
of the Company in sufficient number of shares to permit the exercise of the RSU Grant in accordance with the vesting conditions and exercise
date set forth in this Agreement. Notwithstanding the foregoing, if the Executive dies, becomes Permanently Incapacitated, resigns for
Good Reason or is terminated without Cause prior to the first anniversary of the Effective Date of the Initial Agreement, the RSU Grant
shall automatically vest and the underlying RSU Shares shall be delivered to Executive upon the earlier to occur of (i) the 5th anniversary
of the date of this Agreement and (ii) the date of any change of control transaction of the Company.

 

(e).
Signing Bonus. As consideration for entering into the Initial Agreement, the Company paid to the Executive a one-time signing
bonus (the “Signing Bonus”) in the amount of $250,000 (less such withholdings and deductions as required by applicable
law and regulation and consistent with the Company’s practices). In the event the Executive is terminated for Cause (as defined
in this Agreement) or resigns other than for Good Reason (as defined in this Agreement) on or before the second anniversary of the Effective
Date, the Executive shall be obligated to repay to the Company the Signing Bonus within 14 days of the Executive’s last day of
employment. Moreover, unless there is a good faith dispute between Executive and the Company as to whether Executive is required to repay
the Signing Bonus in accordance with the immediately preceding sentence, in the event the Company is required to initiate legal proceedings
to recoup the Signing Bonus, the Executive shall reimburse the Company for all attorneys’ fees and legal costs associated with
recouping the Signing Bonus. For purposes of clarity, if the Executive dies, becomes Permanently Incapacitated, resigns for Good Reason
or is terminated without Cause, the Executive shall not be required to repay the Signing Bonus.

 

    	-6-

    	 

    

 

(f).
Expenses. The Executive shall be reimbursed for all ordinary and necessary out-of-pocket business expenses reasonably and actually
incurred or paid by the Executive in the performance of the Executive’s duties in accordance with the Company’s policies
applicable to executives of like seniority, and in the case of travel and accommodation expenses, applicable to the CEO and President
of the Company (but subject to the specific approval of the CEO or the President of the Company in each instance) upon presentation of
such expense statements or vouchers or such other supporting information as the Company may require.

 

(g).
Benefits. The Executive shall be entitled to fully participate in all benefit plans that are in place and available to the CEO
and President of the Company from time to time, including, without limitation, medical, dental, vision and life insurance (if offered),
in each case subject to the general eligibility, participation and other provisions set forth in such plans. Without limiting the foregoing,
with respect to Executive’s services, the Company shall indemnify Executive to the maximum extent set forth in the organizational
documents of the Company and Executive shall be covered on a Company directors and officers errors and omissions insurance policy to
the same extent that any other person is so covered.

 

(h).
Paid Time Off. The Executive shall be entitled to paid time off based on the Company’s policies applicable to other C-level
executives in effect from time to time, provided such duration shall not be less than four weeks annually.

 

(i).
Clawback Provisions. Notwithstanding any other provisions in this Agreement to the contrary, any incentive-based compensation,
or any other compensation, paid to the Executive pursuant to this Agreement or any other agreement or arrangement with the Company which
is subject to recovery under any law, government regulation, or stock exchange listing requirement, will be subject to such deductions
and clawback as may be required to be made pursuant to such law, government regulation, or stock exchange listing requirement.

 

1.3
Term; Termination of Employment.

 

(a).
Term. The Executive’s initial term of employment hereunder shall begin on the Effective Date, and, unless earlier terminated
pursuant to Sections 1.3(b) or 1.3(c), shall continue until the second anniversary of the Effective Date of the Initial Agreement (the
“Initial Term”), and, if not so earlier terminated, shall be automatically renewed for additional one (1) year terms
(each a “Renewal Term”, and together with the Initial Term, the “Term”) thereafter unless written
notice to the contrary is provided by either party to the other at least ninety (90) days prior to the expiration of the Initial Term
or then-existing Renewal Term, as applicable.

 

(b).
Early Termination. The term of this Agreement may be earlier terminated by the Executive or the Company as follows:

 

(i).
Termination for Cause. The Company may terminate the Executive’s employment at any time for Cause upon written notice to
the Executive setting forth the termination date and, in reasonable detail, the circumstances claimed to provide a basis for termination
pursuant to this Section 1.3(b)(i), without any requirement of a notice period and without payment of any compensation of any nature
or kind; provided, however, that if the Cause is pursuant to subsections (i), (ii), (vi) or (vii) of the definition of
Cause (appearing below), the Chief Executive Officer must give the Executive the written notice referenced above within (30) days of
the date that the Chief Executive becomes aware or has knowledge of, or reasonably should have become aware or had knowledge of, such
act or omission, and the Executive will have thirty (30) days to cure such act or omission. Upon payment of the amounts set forth in
Section 1.3(d), the Executive shall not be entitled to any benefits or payments (other than those required under Section 1.3(d) hereof),
including any payment under the terms of the Plan.

 

    	-7-

    	 

    

 

(ii).
Termination without Cause. The Company may terminate the Executive’s employment at any time without Cause upon written notice
to the Executive, subject to Section 1.3(c) and 1.3(d).

 

(iii).
Permanent Incapacity. In the event of the “Permanent Incapacity” of the Executive (which shall mean by reason
of illness or disease or accidental bodily injury, the Executive is so disabled that the Executive is unable to ever work again), the
Executive may thereupon be terminated by the Company upon written notice to the Executive without payment of any severance of any nature
or kind (including, without limitation, by way of anticipated earnings, damages or payment in lieu of notice); provided that, in the
event of the Executive’s termination pursuant to this Subsection 1.3(b)(iii), the Company shall pay or cause to be paid to the
Executive (i) the amounts specified in Section 1.2(b), provided that the Executive signs and does not revoke the release agreement referred
to in Section 1.3(c)(iii), and amounts prescribed by Section 1.3(d) below through the date of Permanent Incapacity, and (ii) the amounts
specified in any benefit and insurance plans applicable to the Executive as being payable in the event of the permanent incapacity or
disability of the Executive, such sums to be paid in accordance with the provisions of those plans as then in effect.

 

(iv).
Death. If the Executive’s employment is terminated by reason of the Executive’s death, the Executive’s beneficiaries
or estate will be entitled to receive and the Company shall pay or cause to be paid to them or it, as the case may be, (i) the amounts
specified in Section 1.2(b), provided that the Executive signs and does not revoke the release agreement referred to in Section 1.3(c)(iii),
and amounts prescribed by Section 1.3(d) through the date of death, and (ii) the amounts specified in any benefit and insurance plans
applicable to the Executive as being payable in the event of the death of the Executive, such sums to be paid in accordance with the
provisions of those plans as then in effect.

 

(v).
Termination by Executive. The Executive may terminate employment with the Company upon giving 30 days’ written notice or
such shorter period of notice as the Company may accept. The Executive may resign for Good Reason subject to Section 1.3(c) and 1.3(d).
If the Executive resigns for any reason not constituting Good Reason, the Executive shall not be entitled to any severance or other benefits
(other than those required under Section 1.3(d)).

 

(c).
Termination without Cause or by the Executive for Good Reason. If the Executive’s employment with the Company is terminated
prior to the end of the Term, by the Company without Cause or by the Executive for Good Reason, then the Executive shall receive the
payments and benefits described in this Section 1.3(c).

 

    	-8-

    	 

    

 

(i).
Executive shall be entitled to (i) any amounts owed to the Executive pursuant Section 1.3(d), (ii) if Executive dies, becomes Permanently
Incapacitated, is terminated for Cause or resigns for Good Reason prior to the first anniversary of the Effective Date, the RSU Grant
and RSU Shares in accordance with Section 1.2(d), (iii) any amount owed pursuant to Section 1.2; (iv) if such termination occurs during
the Initial Term, to receive salary continuation (i.e., not a lump sum payment) through the longer of (x) the end of the Initial Term
and (y) one year following the Executive’s date of termination (the “Termination Date”), and (v) if such termination
occurs during a Renewal Term, to receive salary continuation (i.e., not a lump sum payment) for a period of one year following the Termination
Date. The period through which severance is paid pursuant to subclause (iv) or subclause (v) to the Executive hereunder is referred to
herein as the “Severance Period”. Payments described in subclause (iv) or subclause (v) hereunder shall commence to
be paid on the 60th day following the Termination Date, provided that the first payment shall include all of the payments which should
have been paid prior to such date, but were not paid as a result of this sentence.

 

(ii).
If the Executive elects to receive continued medical, dental or vision coverage under one or more of the Company’s healthcare plans
pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), the Company shall directly
pay, or reimburse the Executive, a portion of the COBRA premiums (based on the amount paid by the Company immediately prior to the Executive’s
Termination Date) for the Executive and the Executive’s covered dependents under such plans during the period commencing on the
Termination Date and ending upon the earliest of (X) the expiration of the Severance Period, (Y) the date that the Executive and/or Executive’s
covered dependents become no longer eligible for COBRA or (Z) the date the Executive becomes eligible to receive healthcare coverage
from a subsequent employer (and the Executive agrees to promptly notify the Company of such eligibility). Notwithstanding the foregoing,
if the Company cannot provide the foregoing COBRA premiums without potentially violating applicable law (including, without limitation,
Section 2716 of the Public Health Service Act) or incurring an excise tax, the Company shall in lieu thereof provide to the Executive
a taxable monthly payment in an amount equal to the monthly COBRA premium that the Executive would be required to pay to continue Executive’s
and Executive’s covered dependents’ group health coverage in effect on the Termination Date (which amount shall equal the
amount paid by the Company immediately prior to the Executive’s Termination Date), less the amount Executive would have had to
pay to receive group health coverage for Executive and Executive’s covered dependents based on the cost sharing levels in effect
on the Termination Date, which payments shall be made regardless of whether the Executive elects COBRA continuation coverage and shall
commence in the month following the month in which the Termination Date occurs and shall end on the earlier of (X) the expiration of
the Severance Period, (Y) the date that the Executive and/or Executive’s covered dependents become no longer eligible for COBRA
or (Z) the date the Executive becomes eligible to receive healthcare coverage from a subsequent employer (and Executive agrees to promptly
notify the Company of such eligibility).

 

(iii).
The payments and benefits described in Section 1.3(c)(i) and Section 1.3(c)(ii), along with the vesting features of the Executive’s
equity awards as set forth in this Agreement, are the only severance, benefits or other payments in lieu of notice that the Executive
will be entitled to receive under this Agreement. Any right of the Executive (or the Executive’s estate) to payments and benefits
pursuant to Section 1.3(c)(i) and Section 1.3(c)(ii) shall be contingent on Executive (or an authorized representative of Executive’s
estate) signing and not revoking a standard form of release agreement with the Company in the form attached hereto as Exhibit A
(as such form may be modified solely to the extent required to conform to applicable laws).

 

    	-9-

    	 

    

 

(d).
Company Obligations upon Termination. Upon termination of Executive’s employment pursuant to any of the circumstances listed
in Section 1.3(b), Executive (or Executive’s estate) shall be entitled to receive: (i) the portion of Executive’s Annual
Salary earned through the date of termination, but not yet paid to Executive, (ii) any vacation time that has been accrued but unused
to the extent consistent with Company policy, (iii) any expense reimbursements owed to Executive pursuant to this Agreement, and (iv)
any amount accrued and arising from Executive’s participation in, or benefits accrued under any employee benefit plans, programs
or arrangements, which amounts shall be payable in accordance with the terms and conditions of such employee benefit plans, programs
or arrangements.

 

(e).
Statutory Deductions. All payments required to be made to the Executive, his beneficiaries, or his estate under this Section shall
be made net of all deductions required to be withheld by applicable law and regulation. The Executive shall be solely responsible for
the satisfaction of any taxes (including employment taxes imposed on employees and taxes on nonqualified deferred compensation). Although
the Company intends and expects that the Plan and its payments and benefits will not give rise to taxes imposed under Code Section 409A,
unless the Company is in breach of its obligations hereunder or applicable law with respect to taxes imposed under Code Section 409A,
neither the Company nor its employees, directors, or their agents shall have any obligation to hold the Executive harmless from any or
all of such taxes or associated interest or penalties.

 

(f).
Fair and Reasonable, etc. The parties acknowledge and agree that the payment provisions contained in this Section are fair and
reasonable, and the Executive acknowledges and agrees that such payments are inclusive of any notice or pay in lieu of notice or vacation
or severance pay to which he would otherwise be entitled under statute, pursuant to common law or otherwise in the event that his employment
is terminated pursuant to or as contemplated in this Section 1.3.

 

1.4
Restrictive Covenants.

 

(a).
Non-Solicitation of Employees. During the Executive’s employment and for a period of one year following the termination
of the Executive’s employment with the Company for any reason, the Executive agrees and covenants not to directly or indirectly,
alone or in concert with others, solicit, encourage, influence, recruit, or induce or attempt to solicit, encourage, influence, recruit
or induce, or direct any other person or entity to take any of the aforementioned actions, any employee of the Company to cease working
for the Company and/or to begin working with any other person or entity. This non-solicitation provision explicitly covers all forms
of oral, written, or electronic communication, including, but not limited to, communications by email, regular mail, express mail, telephone,
fax, instant message, and social media, including, but not limited to, Facebook, LinkedIn, Instagram, and Twitter, and any other social
media platform, whether or not in existence at the time of entering into this Agreement.

 

    	-10-

    	 

    

 

Notwithstanding
the foregoing, this Section shall not deemed to have been breached or violated by the placement of general advertisements that may be
targeted to a particular geographic or technical area but that are not specifically targeted toward employees of the Company.

 

(b).
Non-Solicitation of Customers. The Company has a legitimate business interest in protecting its substantial and ongoing customer
relationships. The Executive understands and acknowledges that because of the Executive’s experience with and relationship to the
Company, the Executive will have access to and learn about much or all of the Company’s customer information. “Customer
Information” includes, but is not limited to, names, phone numbers, addresses, e-mail addresses, order history, order preferences,
chain of command, pricing information, and other information identifying facts and circumstances specific to the customer and relevant
to customer sales and the provision to customers of services.

 

The
Executive understands and acknowledges that loss of this customer relationship and/or goodwill will cause significant and irreparable
harm.

 

In
exchange for the Executive’s employment by the Company, and based on the Executive’s access to Customer Information during
the Executive’s employment and/or after the termination of the Executive’s employment with the Company for any reason, the
Executive agrees and covenants that, during the Executive’s employment and for a period of one year following the termination of
the Executive’s employment with the Company for any reason, the Executive will not directly or indirectly solicit, contact (including
but not limited to e-mail, regular mail, express mail, telephone, fax, instant message, or social media, including but not limited to
Facebook, LinkedIn, Instagram or Twitter, or any other social media platform, whether or not in existence at the time of entering into
this Agreement), attempt to contact, or meet with the Company’s customers or prospective customers as described below for purposes
of offering or accepting goods or services competitive with those offered by the Company.

 

This
restriction shall only apply to:

 

(i).
Customers the Executive contacted in any way during the past 12 months;

 

(ii).
Customers about whom the Executive has trade secret or confidential information;

 

(iii).
Customers who became customers during the Executive’s employment with the Company;

 

(iv).
Customers about whom the Executive has information that is not available publicly; and

 

(v).
Prospective customers with whom the Executive is engaged in active sales communications or with whom the Executive is aware that the
Company is otherwise engaged in active sales communications.

 

    	-11-

    	 

    

 

(c).
Confidential Information; Proprietary Rights. The Executive has had and shall continue to have access to the trade secrets, business
plans, and production processes of the Company. Accordingly, the Executive shall comply with and shall remain subject to the terms of
the Employee Confidentiality and Proprietary Rights Agreement, dated on or about the date of the Initial Agreement (“Confidentiality
Agreement”), whose terms are fully incorporated by reference into this Agreement.

 

(d).
Acknowledgment by the Executive. The Executive acknowledges and confirms that: (i) the restrictive covenants contained in this
Section 1.4 are reasonably necessary to protect the legitimate business interests of the Company; (ii) the restrictions contained in
this Section 1.4 (including, without limitation, the length of the term of the provisions of this Section 1.4) are not overbroad, overlong,
or unfair and are not the result of overreaching, duress, or coercion of any kind; and (iii) the Executive’s entry into this Agreement
and, specifically this Section 1.4, is a material inducement and required condition to the Company’s entry into this Agreement.

 

(e).
Reformation by Court. In the event that a court of competent jurisdiction shall determine that any provision of this Section 1.4
is invalid or more restrictive than permitted under the governing law of such jurisdiction, then only as to enforcement of this Section
1.4 within the jurisdiction of such court, such provision shall be interpreted and enforced as if it provided for the maximum restriction
permitted under such governing law.

 

(f).
Survival. The provisions of this Section 1.4 shall survive the termination of this Agreement.

 

(g).
Injunction. It is recognized and hereby acknowledged by the parties hereto that a breach by the Executive of any of the covenants
contained in this Section 1.4 will cause irreparable harm and damage to the Company, the monetary amount of which may be virtually impossible
to ascertain. As a result, the Executive recognizes and hereby acknowledges that the Company shall be entitled to an injunction from
any court of competent jurisdiction enjoining and restraining any violation of any or all of the covenants contained in this Section
1.4 by the Executive or any of Executive’s Affiliates, associates, partners or agents, either directly or indirectly, and that
such right to injunction shall be cumulative and in addition to whatever other remedies the Company may possess.

 

1.5
Definitions. The following capitalized terms used herein shall have the following meanings:

 

(a).
“Affiliate” shall mean, with respect to any Person, any other Person, directly or indirectly, controlling, controlled
by or under common control with such Person.

 

(b).
“Agreement” shall mean this Agreement, as amended from time to time.

 

(c).
“Annual Revenue Target” shall mean, in respect of any calendar year, an amount, as determined by the Board or the
Compensation Committee of the Board, as it may be adjusted from time to time to take into account material strategic developments in
the Company’s business, such as the acquisition of new businesses or the effects of market-wide conditions outside the Company’s
control, and as in effect on the last day of such calendar year, comprising an aggregate of the Company’s annual revenue with respect
to the following revenue streams:

 

    	-12-

    	 

    

 

(i).
Sponsorship revenue for directly sold print and digital display advertising;

 

(ii).
Programmatic private marketplace revenue (“PMP”) and programmatic guaranteed (“PG”) display revenue,
but not open market display revenue; and

 

(iii).
All digital video revenue, including open market, directly sold, PMP and PG.

 

(d).
“Annual Salary” shall have the meaning specified in Section 1.2(a).

 

(e).
“Board” shall mean the Board of Directors of the Company.

 

(f).
“Cause” means the (i) Executive’s willful and continued failure substantially to perform the duties of the Executive
under this Agreement (other than any such failure resulting from incapacity due to physical or mental illness), provided that the mere
failure to achieve specified objectives shall not constitute Cause; (ii) the Executive’s willful and continued failure to comply
with any valid and legal directive of the Chief Executive Officer in accordance with this Agreement, provided that the mere failure to
achieve specified objectives shall not constitute Cause; (iii) the Executive’s engagement in illegal conduct or willful misconduct,
which is, in each case, materially and demonstrably injurious to the Company or its Affiliates; (iv) the Executive’s embezzlement,
misappropriation, or fraud against the Company or any of its Affiliates; (v) the Executive’s conviction of or plea of guilty or
nolo contendere to a crime that constitutes a felony (or state law equivalent), if such felony is work-related, materially impairs the
Executive’s ability to perform services for the Company, or results in a material loss to the Company or material damage to the
reputation of the Company; (vi) the Executive’s failure to comply in any material respect with a material policy of the Company
that has been previously delivered to the Executive in writing if such failure causes material harm to the Company; or (vii) the Executive’s
material breach of any material obligation under this Agreement or any other written agreement between the Executive and the Company.
No act or failure to act on the part of the Executive shall be considered “willful” unless it is done, or omitted to be done,
by the Executive in bad faith or without reasonable belief that the Executive’s action or omission was in the best interests of
the Company.

 

(g).
“Code” shall have the meaning of the Internal Revenue Code of 1986, as it may be amended from time to time.

 

(h).
“Company” shall have the meaning specified in the introductory paragraph hereof; provided that, (i) “Company”
shall include any successor to the Company and (ii) for purposes of Section 1.4, the term “Company” also shall include any
existing or future subsidiaries of the Company that are operating during the Term of this Agreement.

 

    	-13-

    	 

    

 

(i).
“Good Reason” shall mean any of the following events, which has not been either consented
to in advance by the Executive in writing or, with respect only to subsections (ii), or (v) below, cured by the Company within
a reasonable period of time, not to exceed 30 days, after the Executive provides written notice within 30 days of the initial existence
of (or, if later, the Executive’s knowledge of the existence of) one or more of the following events: (i) a decrease in the Annual
Salary; (ii) a material breach of this Agreement, or any other written agreement between the Executive
and the Company, by the Company; (iii) a material diminution or reduction
in the Executive’s responsibilities, duties or authority; (iv) requiring the Executive
to take any action which would violate any federal or state law; or (v) any requirement that the Executive’s
duties be performed more than 50 miles outside of New York City more than two (2) days per week on average, (it being understood that
certain weeks will require lengthier stays outside of New York City). Good Reason shall not exist
unless the Executive terminates his employment within seventy-five (75) days following the initial existence of (or, if later, the Executive’s
knowledge of the existence of) the condition or conditions that the Company has failed to cure, if
applicable. 

 

(j).
“Person” shall mean any individual, corporation (including any non-profit corporation), general partnership, limited
partnership, limited liability partnership, joint venture, estate, trust, company (including any limited liability company or joint stock
company), firm or other enterprise, association, organization or entity.

 

Article
2. 

MISCELLANEOUS
PROVISIONS

 

2.1
Further Assurances. Each of the parties hereto shall execute and cause to be delivered to the other party hereto such instruments
and other documents, and shall take such other actions, as such other party may reasonably request for the purpose of carrying out or
evidencing any of the transactions contemplated by this Agreement.

 

2.2
Notices. All notices hereunder shall be in writing and shall be sent by (a) certified or registered mail, return receipt requested,
(b) national prepaid overnight delivery service, (c) electronic transmission (following with hard copies to be sent by prepaid overnight
delivery Service) or (d) personal delivery with receipt acknowledged in writing. All notices shall be addressed to the parties hereto
at their respective addresses as set forth below (except that any party hereto may from time to time upon fifteen days’ written
notice change its address for that purpose), and shall be effective on the date when actually received or refused by the party to whom
the same is directed (except to the extent sent by registered or certified mail, in which event such notice shall be deemed given on
the third day after mailing).

 

(a).
If to the Company:

 

TheMaven,
Inc.

1500
Fourth Avenue, Suite 200

Seattle,
WA 98101

Email:
hr@maven.io

 

(b).
If to the Executive:

 

Avi
Zimak

392
River Road

Chatham,
NJ 07928

Email:
avizimak@gmail.com

 

    	-14-

    	 

    

 

2.3
Headings. The underlined or boldfaced headings contained in this Agreement are for convenience of reference only, shall not be
deemed to be a part of this Agreement and shall not be referred to in connection with the construction or interpretation of this Agreement.

 

2.4
Counterparts. This Agreement may be executed in several counterparts, each of which shall constitute an original and all of which,
when taken together, shall constitute one agreement.

 

2.5
Governing Law; Jurisdiction and Venue.

 

(a).
This Agreement shall be construed in accordance with, and governed in all respects by, the internal laws of the State of New York (without
giving effect to principles of conflicts of laws), except to the extent preempted by federal law.

 

(b).
Any legal action or other legal proceeding relating to this Agreement or the enforcement of any provision of this Agreement shall be
brought or otherwise commenced exclusively in any state or federal court located in New York County,
New York.

 

2.6
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their successors
and assigns (if any). The Company will use commercially reasonable efforts to require any successor (whether direct or indirect, by purchase,
merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company expressly to assume and
agree to perform this Agreement in the same manner and to the same extent that the Company would have been required to perform it if
no such succession had taken place. As used in this Agreement, “Company” shall mean both the Company as defined above and
any such successor that assumes and agrees to perform this Agreement, by operation of law or otherwise. The Executive shall not assign
this Agreement or any of the Executive’s rights or obligations hereunder (by operation of law or otherwise) to any Person without
the consent of the Company.

 

2.7
Remedies Cumulative; Specific Performance. The rights and remedies of the parties hereto shall be cumulative (and not alternative).
The parties to this Agreement agree that, in the event of any breach or threatened breach by any party to this Agreement of any covenant,
obligation or other provision set forth in this Agreement for the benefit of any other party to this Agreement, such other party shall
be entitled (in addition to any other remedy that may be available to it) to (a) a decree or order of specific performance or mandamus
to enforce the observance and performance of such covenant, obligation or other provision, and (b) an injunction restraining such breach
or threatened breach. The parties to this Agreement further agree that in the event the Executive prevails on any material claim (in
a final adjudication) in any legal proceeding brought against the Company to enforce the Executive’s rights under this Agreement,
the Company will reimburse the Executive for the reasonable legal fees incurred by the Executive in connection with such proceeding.

 

    	-15-

    	 

    

 

2.8
Waiver. No failure on the part of any Person to exercise any power, right, privilege or remedy under this Agreement, and no delay
on the part of any Person in exercising any power, right, privilege or remedy under this Agreement, shall operate as a waiver of such
power, right, privilege or remedy and no single or partial exercise of any such power, right, privilege or remedy shall preclude any
other or further exercise thereof or of any other power, right, privilege or remedy. No Person shall be deemed to have waived any claim
arising out of this Agreement, or any power, right, privilege or remedy under this Agreement, unless the waiver of statutory claim, power,
right, privilege or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such Person; and any
such waiver shall not be applicable or have any effect except in the specific instance in which it is given.

 

2.9
Code Section 409A Compliance. To the extent amounts or benefits that become payable under this Agreement on account of the Executive’s
termination of employment (other than by reason of the Executive’s death) constitute a distribution under a “nonqualified
deferred compensation plan” within the meaning of Code Section 409A (“Deferred Compensation”), the Executive’s
termination of employment shall be deemed to occur on the date that the Executive incurs a “separation from Service” with
the Company within the meaning of Treasury Regulation Section 1.409A-1(h). If at the time of the Executive’s separation from service,
the Executive is a “specified Executive” (within the meaning of Code Section 409A and Treasury Regulation Section 1.409A-1(i)),
the payment of such Deferred Compensation shall commence on the first business day of the seventh month following the Executive’s
separation from Service and the Company shall then pay the Executive, without interest, all such Deferred Compensation that would have
otherwise been paid under this Agreement during the first six months following the Executive’s separation from service had the
Executive not been a specified Executive. Thereafter, the Company shall pay Executive any remaining unpaid Deferred Compensation in accordance
with this Agreement as if there had not been a six-month delay imposed by this paragraph. If any expense reimbursement by the Executive
under this Agreement is determined to be Deferred Compensation, then the reimbursement shall be made to the Executive as soon as practicable
after submission for the reimbursement, but no later than December 31 of the year following the year during which such expense was incurred.
Any reimbursement amount provided in one year shall not affect the amount eligible for reimbursement in another year and the right to
such reimbursement shall not be subject to liquidation or exchange for another benefit. In addition, if any provision of this Agreement
would subject the Executive to any additional tax or interest under Code Section 409A, then the Company shall, subject to the Executive’s
consent (such consent not be unreasonably withheld, conditioned or delayed), reform such provision; provided that the Company
shall (x) maintain, to the maximum extent practicable, the original intent of the applicable provision without subjecting the Executive
to such additional tax or interest and (y) not incur any additional compensation expense as a result of such reformation. For purposes
of Code Section 409A, Executive’s right to receive installment payments pursuant to this Agreement shall be treated as a right
to receive a series of separate and distinct payments.

 

2.10
Amendments. This Agreement may not be amended, modified, altered or supplemented other than by means of a written instrument duly
executed and delivered on behalf of all of the parties hereto.

 

    	-16-

    	 

    

 

2.11
Severability. In the event that any provision of this Agreement, or the application of any such provision to any Person or set
of circumstances, shall be determined to be invalid, unlawful, void or unenforceable to any extent, the remainder of this Agreement,
and the application of such provision to Persons or circumstances other than those as to which it is determined to be invalid, unlawful,
void or unenforceable, shall not be impaired or otherwise affected and shall continue to be valid and enforceable to the fullest extent
permitted by law,

 

2.12
Parties in Interest. Except as provided herein, none of the provisions of this Agreement are intended to provide any rights or
remedies to any Person other than the parties hereto and their respective successors and assigns (if any).

2.13
Public Announcements. Neither the Company nor Executive shall issue any press release or similar public announcement regarding
this Agreement or Executive’s employment with the Company without the consent of the other party (such consent not to be unreasonably
withheld, conditioned or delayed).

 

2.14
Entire Agreement. This Agreement and its Exhibits, and the Confidentiality Agreement, set forth the entire understanding of the
parties hereto relating to the subject matter hereof and supersedes all prior agreements, term sheets and understandings between the
parties relating to the subject matter hereof.

 

[SIGNATURE
PAGE TO EXECUTIVE

EMPLOYMENT
AGREEMENT TO FOLLOW]

 

    	-17-

    	 

    

 

[SIGNATURE
PAGE TO EXECUTIVE EMPLOYMENT AGREEMENT]

 

The
parties hereto have caused this Agreement to be executed and delivered as of the date first set forth above.

 

	 	THE
    COMPANY:

 

	 	THEMAVEN,
    INC.

 

	 	By:	 
	 	Name:
    	 
	 	Title:
    	 

 

	 	THE
    EXECUTIVE:

 

	 	
	 	Avi
    Zimak

 

    	-18-

    	 

    

 

EXHIBIT
A

 

SEPARATE
AGREEMENT AND RELEASE

 

Attached.

 

    	-19-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}]]